Be an active participant
in choosing the best
treatment for your
severe asthma symptoms
Be an active participant
in choosing the best
treatment for your
severe asthma symptoms
Be an active participant
in choosing the best
treatment for your
severe asthma symptoms
If you struggle to manage your asthma, it may be time to talk to your doctor about additional treatment options.
This tool enables a frank and open discussion between you and your asthma specialist about your severe asthma and which treatment options make the most sense for you. The tool takes into consideration a variety of treatment options based on both the medical validity of each treatment, as well as your preferences and values. It begins with a series of questions to focus in on your current asthma symptoms and challenges, as well as questions that highlight your treatment preferences and any lifestyle constraints that may limit your ability to adopt specific treatment options.
Once you’ve completed the questions, you and your doctor will examine and discuss the pros and cons of treatment options that might be right for you so that together you can decide on the best course of action. Finally, the tool also offers downloadable information with more detail about the treatment option you and your doctor select.
Ultimately, by working together with your doctor to determine your best next step, you can achieve the most important goals of reducing asthma symptoms and improving the quality of your life.

Please Note

Non-FDA approved treatments are not included in this tool because they have not yet been shown in clinical studies to be safe and effective, and are, therefore, not covered by insurance.

The information and reference materials contained here are intended solely for the general information of the reader. They are not to be used for treatment purposes, but rather for discussion with the patient’s own asthma specialist. The information presented here is not intended to diagnose health problems or to take the place of professional medical care.